Table 1.
PTM category | Substrates | Key regulators | Effects of PTM in ferroptosis | Ref |
---|---|---|---|---|
Ubiquitination |
FSP1 |
TRIM21, TRIM69, TRIM56 |
K63-linked ubiquitination enhances plasma membrane localization of FSP1 and inhibits ferroptosis; K48-linked ubiquitination enhances degradation of FSP1 and promotes ferroptosis |
[56,143,145] |
Phosphorylation | DHODH | LOXL3 | Enhances degradation of DHODH and promotes ferroptosis | [66] |
TFRC | HUWE1, BTRC |
Enhances degradation of TFRC and inhibits ferroptosis | [108,109] | |
LTF | NEDD4L | Enhances degradation of LTF and promotes ferroptosis | [110] | |
SLC40A1 | RNF217, USP35 |
Enhances degradation of SLC40A1 and promotes ferroptosis | [111,112] | |
IRP2 | FBXL5 | Enhances degradation of IRP2 and inhibits ferroptosis | [114] | |
SLC7A11 | BTRC, HECTD3, NEDD4L, SOCS2, SYVN1, TRIM26, ZRANB1, OTUB1, USP20 |
Enhances degradation of SLC7A11 and promotes ferroptosis | [6,[115], [116], [117], [118], [119], [120], [121], [122]] | |
GPX4 | FBXO31, NEDD4, NEDD4L, STUB1, TRIM21, TRIM25, TRIM26, TRIM59, LUBAC, OTUB1, OTUD5, USP31 |
Enhances degradation of GPX4 and promotes ferroptosis | [[126], [127], [128], [129], [130], [131], [132], [133], [134]] | |
ACSL4 | RNF146, NEDD4L, MARCHF6 |
Enhances degradation of ACSL4 and inhibits ferroptosis | [[146], [147], [148]] | |
GSTP1 | SMURF2 | Enhances degradation of GSTP1 and promotes ferroptosis | [34] | |
VDAC2/3 | NEDD4, FBXW7 |
Enhances degradation of VDAC2/3 and inhibits ferroptosis | [150,151] | |
NFE2L2 | KEAP1, MIB1, USP11 |
Enhances degradation of NFE2L2 and promotes ferroptosis | [87,154,155] [156] | |
HELLS | DCAF8, USP5, USP11 |
Enhances degradation of HELLS and promotes ferroptosis | [[158], [159], [160]] | |
NCOA4 | TRIM7, FBXW7 |
Enhances degradation of NCOA4 and inhibits ferroptosis | [161,162] | |
BECN1 | USP11 | Enhances degradation of BECN1 and inhibits ferroptosis | [163] | |
GPX4 | CKB | Decreases degradation of GPX4 and inhibits ferroptosis | [58] | |
Acetylation | ACSL4 | PKCBII | Enhances dimerization of ACSL4 and promotes ferroptosis | [63] |
HSPB1 | PKC | Enhances function of HSPB1 and inhibits ferroptosis | [64] | |
EIF4E | NA | Enhances formation of EIF4E-ALDH1B1 complex and promotes ferroptosis | [33] | |
UMPS | AMPK | Enhances function of DHODH and inhibits ferroptosis | [65] | |
HPCAL1 | PRKCQ | Enhances function of HPCAL1 and promotes ferroptosis | [70] | |
BECN1 | AMPK | Enhances function of BECN1 and promotes ferroptosis | [71] | |
TP53 | CREBBP, SIRT1 |
Enhances function of TP53 and promotes ferroptosis | [76,77] | |
O-GlcNAcylation | ALOX12 | CTH | Enhances function of ALOX12 and promotes ferroptosis | [78] |
HSPA5 | EP300 | Enhances function of HSPA5 and inhibits ferroptosis | [79] | |
Histone | KAT5, EHMT2, SIRT1 |
Context-specific effects | [81,83] | |
SLC7A11 | OGT | Enhances function of SLC7A11 and inhibits ferroptosis | [84] | |
SUMOylation | YAP1 | OGT | Enhances function of YAP1 and promotes ferroptosis | [85,86] |
ZEB1 | OGT | Enhances function of ZEB1 and promotes ferroptosis | [85,86] | |
JUN | OGT | Enhances function of JUN and promotes ferroptosis | [89] | |
Ferritin | OGT | Enhances binding of ferritin and NCOA4 and promotes ferroptosis | [90] | |
ACSL4 | SENP1 | Decreases degradation of ACSL4 and promotes ferroptosis | [92] | |
Methylation | HIF1A | SENP1 | Enhances function of HIF1A and promotes ferroptosis | [93] |
ACSL4 | CARM1 | Enhances degradation of ACSL4 and inhibits ferroptosis | [97] | |
N-myristoylation | NFE2L2 | CARM1 | Decreases function of NEF2L2 and promotes ferroptosis | [98] |
OTUB1 | SETD7 | Decrease binding of OTUB1 and UBE2N, and promotes ferroptosis | [99] | |
FSP1 | ACSL1 | Enhances plasma membrane localization of FSP1 and inhibits ferroptosis | [43] | |
Palmitoylation | SLC7A11 | ZDHHC8 | Decreases degradation of SLC7A11 and inhibits ferroptosis | [102] |
Oxidative modification | PRDX3 | NA | Enhances function of PRDX3 and promotes ferroptosis | [104] |